icd10free.comPowered by Curo

ICD-10 Coding for Transaminitis Secondary to Rosuvastatin(T46.6X5A, T46.6X, E78.00)

Save

Learn about the ICD-10 coding for transaminitis secondary to rosuvastatin, including documentation requirements and coding pitfalls.

Also known as:
Statin-Induced Liver InjuryRosuvastatin-Induced Hepatotoxicity
Related ICD-10 Code Ranges

Complete code families applicable to Transaminitis Secondary to Rosuvastatin

S00-T88Primary Range

Injury, poisoning and certain other consequences of external causes

→
Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescription
T46.6X5AAdverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter
K71.9Toxic liver disease, unspecified
R74.01Elevation of levels of liver transaminases and lactic acid dehydrogenase [LDH]
Primary ICD-10-CM Codes
Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter
T46.6X5ABillable
Poisoning by, adverse effect of and underdosing of antihyperlipidemic and antiarteriosclerotic drugs
T46.6X
Differential Codes

Alternative codes to consider when ruling out similar conditions

Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), initial encounterT46.6X

Use for accidental overdose rather than adverse effect.

Inflammatory liver disease, unspecifiedK75.9

Use when the cause of liver inflammation is not identified as drug-induced.

Toxic liver disease, unspecifiedK71.9

Documentation & Coding Risks

Avoid these common issues when documenting Transaminitis Secondary to Rosuvastatin.

Failure to document drug as cause of liver injury

Impact

Clinical: May lead to misdiagnosis and inappropriate treatment., Regulatory: Non-compliance with coding standards., Financial: Potential for denied claims or reduced reimbursement.

Mitigation

Ensure documentation explicitly states drug as cause., Use templates to guide documentation.

Using R74.01 without T46.6X5A

Impact

Reimbursement: May lead to lower reimbursement due to incomplete coding., Compliance: Non-compliance with ICD-10 coding guidelines., Data Quality: Inaccurate representation of the patient's condition.

Mitigation

Always pair R74.01 with T46.6X5A for adverse drug reactions.

Coding 'statin intolerance' instead of DILI

Impact

Reimbursement: Incorrect coding may affect DRG assignment., Compliance: Misrepresentation of the patient's condition., Data Quality: Inaccurate clinical data for research and analysis.

Mitigation

Use T46.6X5A for adverse effects, not Z91.14 for intolerance.

Incomplete coding of drug-induced liver injury

Impact

Failure to use both adverse effect and liver condition codes.

Mitigation

Implement coding audits and education on proper code combinations.

Frequently Asked Questions

Related condition guides

Documentation requirements, coding pitfalls and FAQs for conditions coded with T46.6X5A.